Prescription Drug News and Research

RSS

Medicare Part D found to over-reimburse pharmacies for generic drugs

Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022.

5 Dec 2023

Study finds racial disparity in the utilization of crucial prostate cancer therapy

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

1 Dec 2023

Uncle Sam wants you … to help stop insurers’ bogus Medicare Advantage sales tactics

After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new rules: you.

30 Nov 2023

Cannabis vaping linked to increased use of other substances, study finds

Short communication paper examines the link between cannabis vaping and the use of other substances, comparing cannabis vape users to non-vaping cannabis users. It reveals that cannabis vapers are more likely to use other substances like alcohol, tobacco, and illicit drugs, especially among younger demographics.

26 Nov 2023

Sales of respiratory medications key to predicting disease mortality, UK study finds

The value of integrating national longitudinal shopping data into respiratory disease forecasting models.

22 Nov 2023

Racial and socioeconomic integration linked to lower health care expenditure disparities

Differences in health care expenditures between Black and white adults vary substantially with the local level of racial and economic integration, and tend to be low or nonexistent in highly integrated communities, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

3 Nov 2023

Start shopping: Enrollment begins Nov. 1 for most Obamacare insurance plans

For millions of Americans who buy their own health insurance through the Affordable Care Act marketplace, the end of the year brings a day of reckoning: It's time to compare benefits and prices and change to a new plan or enroll for the first time.

31 Oct 2023

Widely available prescription drug can improve IBS symptoms

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today at UEG Week 2023 has found.

16 Oct 2023

Opioid prescribing limits may not worsen patient experience after common surgeries

Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn't play out as expected, a new study finds.

13 Oct 2023

Americans will spend a larger share of their lifetime taking prescription drugs, research finds

An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by Jessica Ho, associate professor of sociology and demography at Penn State.

12 Oct 2023

Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer

Closed Loop Medicine Ltd. today announced that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO).

From Closed Loop Medicine 10 Oct 2023

Trump misplaced blame when he said drug shortages were Biden’s fault

"Under 'Crooked Joe' Biden, there has been a catastrophic increase in shortages of essential medicines."

6 Oct 2023

As covid infections rise, nursing homes are still waiting for vaccines

"Covid is not pretty in a nursing home," said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She twice contracted the disease and is eager to get the newly approved vaccine because she has chronic lymphocytic leukemia, which weakens her immune system.

27 Sep 2023

What happens to health programs if the federal government shuts down?

For the first time since 2019, congressional gridlock is poised to at least temporarily shut down big parts of the federal government — including many health programs.

27 Sep 2023

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

19 Sep 2023

Free online tool could potentially mitigate financial toxicity for some prostate cancer patients

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a new study finds.

5 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023